Evidence map›Paper›PMID 37163450›Full record

ArticleThe Journal of experimental medicine2023

Diet-mediated constitutive induction of novel IL-4+ ILC2 cells maintains intestinal homeostasis in mice.

Wanlin Cui, Yuji Nagano, Satoru Morita, Takeshi Tanoue, Hidehiro Yamane, Keiko Ishikawa, Toshiro Sato, Masato Kubo, Shohei Hori, Tadatsugu Taniguchi and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Wanlin Cui *Department of Microbiology and Immunology, School of Medicine, Keio University, Tokyo, Japan.ORCID 0000-0002-5969-6263
Yuji Nagano *RIKEN Center for Integrative Medical Sciences (IMS) , Yokohama, Japan.ORCID 0009-0007-0434-8396
Satoru Morita *Department of Microbiology and Immunology, School of Medicine, Keio University, Tokyo, Japan.ORCID 0000-0002-5551-8662
Takeshi TanoueDepartment of Microbiology and Immunology, School of Medicine, Keio University, Tokyo, Japan.ORCID 0000-0003-3639-8834
Hidehiro YamaneLaboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0009-0008-3282-2515
Keiko IshikawaDepartment of Organoid Medicine, Sakaguchi Laboratory, School of Medicine, Keio University, Tokyo, Japan.ORCID 0009-0008-8050-8109
Toshiro SatoDepartment of Organoid Medicine, Sakaguchi Laboratory, School of Medicine, Keio University, Tokyo, Japan.ORCID 0000-0001-8353-8137
Masato KuboRIKEN Center for Integrative Medical Sciences (IMS) , Yokohama, Japan.ORCID 0000-0001-7867-3086
Shohei HoriGraduate School of Pharmaceutical Sciences, The University of Tokyo , Tokyo, Japan.ORCID 0000-0001-8770-4593
Tadatsugu TaniguchiGraduate School of Medicine, The University of Tokyo , Tokyo, Japan.ORCID 0000-0001-5212-090X
Masanori HatakeyamaGraduate School of Medicine, The University of Tokyo , Tokyo, Japan.ORCID 0000-0001-7517-2649
Koji AtarashiDepartment of Microbiology and Immunology, School of Medicine, Keio University, Tokyo, Japan.ORCID 0000-0001-5422-0736
Kenya HondaDepartment of Microbiology and Immunology, School of Medicine, Keio University, Tokyo, Japan.ORCID 0000-0001-8937-9835
Keio University · JPAdvanced Institute of Industrial Technology · JPHokkaido University · JPNational Institutes of Health · USRIKEN Center for Integrative Medical Sciences · JPThe University of Tokyo · JPTokyo University of Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Group 2 innate lymphoid cells (ILC2s) expressing IL-5 and IL-13 are localized at various mucosal tissues and play critical roles in the induction of type 2 inflammation, response to helminth infection, and tissue repair. Here, we reveal a unique ILC2 subset in the mouse intestine that constitutively expresses IL-4 together with GATA3, ST2, KLRG1, IL-17RB, and IL-5. In this subset, IL-4 expression is regulated by mechanisms similar to but distinct from those observed in T cells and is partly affected by IL-25 signaling. Although the absence of the microbiota had marginal effects, feeding mice with a vitamin B1-deficient diet compromised the number of intestinal IL-4+ ILC2s. The decrease in the number of IL-4+ ILC2s caused by the vitamin B1 deficiency was accompanied by a reduction in IL-25-producing tuft cells. Our findings reveal that dietary vitamin B1 plays a critical role in maintaining interaction between tuft cells and IL-4+ ILC2s, a previously uncharacterized immune cell population that may contribute to maintaining intestinal homeostasis.

Indexed as

DietIntestinal MucosaThiamineAnimalsGastrointestinal MicrobiomeInterleukin-4InterleukinsMiceMice, Inbred C57BLOrganoidsSpecific Pathogen-Free OrganismsTrinitrobenzenesulfonic AcidInterleukin-4InterleukinsMydgf protein, mouseThiamineTrinitrobenzenesulfonic Acid

Identifiers

PMID37163450
PMCPMC10174189
OpenAlexW4376131799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.